Upcoming clinical trials of a Russian botulism treatment are set to start soon. This information was shared by a senior researcher at the Gamaleya Research Center, a key contributor to the development of the drug. The project is advancing through the early stages of testing as authorities pursue new options for preventing a serious foodborne illness. These developments reflect ongoing national efforts to reinforce public health defenses against botulism and to explore novel therapeutic approaches. According to officials, the initial phase will focus on safety, examining how the drug interacts with human systems and whether it causes any adverse effects in volunteers. The goal is to establish a solid safety profile before proceeding to effectiveness studies in the following stage. (Source: Newspapers.Ru)
